Interleukin 2 (IL-2) is a well-defined soluble product of activated T lymphocytes that has a number of biological activities (1) . These include support of growth factor-dependent T-cell lines in culture, promotion of concanavalin A (Con A)-induced mitogenesis in thymocyte cultures, helper T-cell-replacing factor activity in athymic (nu/nu) mouse spleen cell cultures, and induction ofcytotoxic T-lymphocytes from both thymocytes and nu/nu spleen cell cultures. This lymphokine has been considered to maintain the growth ofT lymphoblasts but not to initiate blastogenesis in the absence of additional mitogen or antigen (2) (3) (4) (5) . Production of IL-2 by normal murine spleen cells is induced by Con A, a T-lymphocyte mitogen, but cannot be appreciably induced in spleen cells of congenitally athymic mice, which are deficient in T lymphocytes (2, 3) . Adherent cells or interleukin 1, a soluble product ofsuch cells, is required for the Con A-induced production of IL-2 by spleen cells, thus explaining the absolute requirement for adherent cells in proliferative responses to mitogens such as Con A (6) (7) (8) . Recently, however, a T-cell hybridoma and several T lymphomas have been described that are induced to produce IL-2 in the absence ofadherent cells or interleukin 1, thus firmly establishingT lymphocytes as the source of IL-2 (9) (10) (11) (12) .
In this report we demonstrate that IL-2 from several sources is indeed mitogenic for spleen cells from both nu/nu and nu/ + mice in the absence ofserum. These results support the finding that an IL-2-like molecule is mitogenic for thymocytes (13) and suggest that many reported less well-defined "mitogenic factors" of similar source and molecular nature may in fact be identical to IL-2. We also show that the mitogenic response to IL-2 is likely a one-cell event, whereas Con A-induced mitogenesis requires three different interacting cell types. Finally, we show that the cells from nu/nu mouse spleens proliferating in response to IL-2 are 80% T lymphocytes by the third day of culture.
METHODS AND MATERIALS Animals. Five-week old nu/nu or nu/+ mice bred on a BALB/c background were grown in specified pathogen-free conditions at the Athymic Mouse Research Center, University of California, San Diego.
Production of Growth Factors. Spleens of nu/+ ex-breeder mice were aseptically removed and single-cell suspensions were prepared by standard procedures. For culture, 5 x 106 nucleated cells per ml were incubated at 370C, with 5% CO2 in air, in serum-free RPMI 1640 medium (GIBCO) supplemented with 50 AiM 2-mercaptoethanol, 25 mM Hepes buffer, 2 mM glutamine, and standard antibiotics. Con A was added at 1.75 Ag/ml and after 24 hours, cell-free supernatants (spleen cell growth factor) were harvested by centrifugation and filter sterilization and stored at -20'C.
Culture supernatants of the hybridoma FS 6-14.13 stimulated with Con A to produce IL-2 (9) were prepared free of serum and kindly provided by S. Swain. IL-2 produced by the lymphoma LBRM 33 and purified as described (14) (Table 1) . Because spleen cell growth factor was produced by stimulation of cells with the T-lymphocyte mitogen Con A, a-methyl mannoside, which specifically inhibits Con A binding, was tested for inhibition of this mitogenesis. As shown, the glycoside blocked 95% of Con A-induced mitogenesis of T-cell-sufficient nu/+ spleen cells but had no effect upon mitogenesis induced by spleen cell growth factor or the B-cell mitogen LPS. Thus, Con A was not required for the mitogenic effect of spleen cell growth factor. Con A itself had no effect on nu/nu spleen cells, as expected because the donor mice are deficient in mature T cells.
Increased DNA synthesis induced in nu/nu spleen cells by spleen cell growth factor was maximal at 3-4 days of incubation ( Fig. 1 ). Spleen cells explanted in culture showed a high DNA synthesis immediately thereafter, but in the absence of growth factor this synthesis dropped precipitously. In the presence of growth factor a subpopulation was induced to proliferate and ,declined only on the fifth day, presumably due to exhaustion of growth factor or essential nutrients, decreasing pH, or accumulation of inhibitors or toxic metabolites. Such declines are characteristic of in vitro mitogenic responses by lymphocytes (16) . Harvesting ofincorporated [3H]thymidine with or without trichloroacetic acid precipitation gave nearly identical values (within 15%), indicating that the unincorporated intracellular pool was small relative to total incorporation into DNA even during the first 4 hr.
Cell culture supernatants similarly prepared from nu/nu spleen cells with Con A were without effect in this assay,. as were supernatants prepared from nu/nu or nu/+ spleen cells without Con A. Thus, activated T lymphocytes appear to be required for growth factor production. The known growth factors insulin, epidermal growth factor, fibroblast growth factor, and plateletderived growth factor were also without activity in this assay, as was synthetic thymopoietin pentapeptide.
Characterization of the Spleen Cell Growth Factor. Using proliferation of nu/nu spleen cells as a specific assay, we partially purified the active spleen cell growth factor by sequential gel filtration chromatography (Fig. 2) . The active moiety was excluded by Sephadex G-15. This excluded material was then lyophilized and fractionated further on G-75 Sephadex. The active material eluted in a single sharp symmetrical peak with an apparent molecular weight of 30,000, which is consistent with that observed for IL-2 (1, 2, 5).
IL-2 from Cloned Cell Lines is a Mitogen. Because the preliminary characterization of spleen cell growth factor suggested that the active moiety might be identical to IL-2, which can be produced similarly (1), we obtained products of two different cloned cell lines that secrete this lymphokine. The hybridoma FS 6-14.13, a fusion of a murine T lymphocyte and the murine thymoma BW 5147, secretes IL-2 in response to Con A (9).
Serum-free culture supernatants of Con A-stimulated 14.13 cells were mitogenic for both nu/nu and nu/+ spleen cells in the assay described above (Table 1) . This activity was not dependent on Con A, as shown by lack of inhibition with a-methyl mannoside. In response to Con A, the murine lymphoma LBRM 33 secretes IL-2 that is indistinguishable from IL-2 produced by Con A-activated spleen cells (14) . Purified IL- 2 from this lymphoma was also mitogenic for spleen cells from nu/nu and nu/+ mice (Table 1 ). This material was free of Con A and it was therefore not surprising that a-methyl mannoside was without effect in blocking its mitogenic activity.
When spleen cell growth factor, Con A-activated FS 6-14.13
culture supernatant, and. purified IL-2 were titrated into nu/ nu spleen cell cultures, a family of parallel dose-response curves was generated (Fig. 3) . Nearly identical curves were generated in the presence of absence of a-methyl mannoside (not shown). In no case were saturating doses reached, implying that even greater mitogenic responses would be attainable at higher doses, which should exist in the immediate microenvironment ofactivated producer cells. The active moiety ofspleen cell growth factor thus appears to be identical to IL-2 in its mitogenic activity as well as molecular weight and cellular source.
Characterization of the Proliferating Cells from nu/nu Spleen. nu/nu spleen cells induced to proliferate with growth factor were treated with monoclonal anti-Thy-1. Partial purification ofthe growth factor. Spleen cell growth factor (25 ml) was lyophilized, resuspended in 7 ml of 1 M acetic acid, and loaded on a 2 x 52 cm Sephadex G-15 column. Fractions (4 ml) eluted with 1 M acetic acid were collected; 300 1d samples ofeach were lyophilized, resuspended to volume in serum-free medium (using NaOH to adjust pH as necessary), and assayed at 50% (vol/vol), using nu/nu spleen cells. (B). Fractions 17-20 above were pooled, lyophilized, resuspended in 1 (Table 2) . Greater than 80% ofthese proliferating nu/nu spleen cells activated by the growth factor were killed. by the anti-T-cell specific reagent, as were nu/+ spleen cells activated by the growth factor or the T-cell mitogen Con A. In contrast, cells induced to proliferate by the B-cell mitogen LPS were not inhibited by this treatment. Complement alone had no effect as compared with complement-free controls (not shown). Thus, the proliferating cells in nu/nu mouse spleen cell cultures induced by growth factor are at least 80% T lymphocytes.
Cell-Cell Interactions in Growth Factor-Induced and Con A-Induced Mitogenesis. Various numbers of spleen cells were cultured in the presence or absence ofeither spleen cell growth factor or Con A. When the logarithms of the resulting responses were plotted against the logarithms of the cell number, straight lines were obtained (Fig. 4) , the slopes of which indicate the minimal number of interacting cell populations that are required to give the response (17, 18) . In three independent. experiments the mean ofthe slopes calculated by the least-squares method for nu/+ spleen cells responding to Con A was 3.18 (SD...= 0.16), indicating a minimum of three interacting cell types. However; for nu/nu spleen cells, responding to spleen cell growth factor, the mean of the calculated slopes was 1.28 (SD = 0.21), indicating a minimum ofone interacting cell population. The presence or absence of a-methyl mannoside had no effect on the nu/nu response to growth factor. In all cases the correlation. coefficient was greater than 0.97. These data strongly suggest that spleen cell growth factor is a direct mitogen for responding cells, whereas Con A-induced mitogenesis is mediated by at least two additional cell types, Effect of Serum on Response to Growth Factor. When similar experiments were attempted in the presence of serum, highly variable results were obtained. In general, increasing concentrations of serum depress the mitogenic response to growth factor and also occasionally stimulate background proliferation so that mitogenesis is masked. Whether serum contains a specific inhibitor of IL-2 or otherwise blocks its action is unknown. Interestingly, the major in vivo sites of lymphoid proliferation are not exposed to serum directly, but rather to an ultrafiltrate that may lack these inhibitory agents. A recent report suggests that normal mouse serum may contain such a high molecular weight inhibitor of IL-2, which diminishes induction of cytotoxic lymphocytes from precursors (19) . The absence of serum in our assay system may explain why we have observed mitogenesis with IL-2, whereas others have not (2) (3) (4) (5) .
DISCUSSION
Results presented in this study indicate that IL-2 is equally mitogenic for unprimed splenocytes from nu/nu and nu/+ mice in the absence of serum. No additional mitogen or antigen is required for this response. Dilutional analyses indicate that the mitogenic response to IL-2 is most likely a direct one-cell event, whereas the mitogenic response to Con A is a three-cell event. IL-2 has previously been reported to possess no mitogenic properties (2) (3) (4) (5) , but to act only as. a "costimulator" in concert with other mitogenic substances. Data presented here clearly indicate that this lymphokine is a potent and direct lymphocyte mitogen when assayed in serum-free cultures. Whether this inherent mitogenicity is due to the expansion of spleen cell populations already proliferating at a low level or to the activation of resting cells is not yet known. Should the latter be the case, then IL-2-induced mitogenesis, being a one-cell event, will provide an excellent model for studying events in the initiation of the cell cycle in normal cells. Not surprisingly, numerous studies using lectin-induced mitogenesis, a three-cell event, to examine early events in lymphocyte activation have produced conflicting results and conclusions. The three cells required for Con A responses are most likely an adherent cell, an IL-2-producing T cell, and the IL-2-responding T-cell. Studies with IL-2 prodicung lymphomas have suggested that IL-2 production may involve a terminal differentiation, implying that cells that produce IL-2 are not the cells that respond to it (10) . Similar dilutional analysis of antigen-induced proliferation has shown that response also to involve three cell types (18) . IL-2 may well be the proximal mitogen in all proliferative events involving T lymphocytes.
Our results also indicate that the cells from T-deficient nu/ nu spleens that proliferate in response to IL-2 are at least 80% T lymphocytes by the third day of culture. Other investigators have reported the long-term growth ofcytotoxic T-cell lines and short-term induction of Thy-i antigen and helper activity from nu/nu mouse spleen cells with Con A supernatants (20) (21) (22) .
Cell Biology: Lipsick and Kaplan Taken together, these results indicate that, although nu/nu spleen cells cannot produce IL-2, they can respond to it. Whether IL-2 causes maturation of T lymphocytes from precursors in nu/nu spleens or only expands the small number of T lymphocytes already present is uncertain. Studies on the expression ofThy-i antigen.by nu/nu spleen cells treated with Con A supernatant support the latter possibility, whereas studies ofthe induction ofhelper activity in the same report support the former possibility (22) .
The present study suggests that IL-2 causes T lymphocytes to mature from precursors in fnu/nu spleens, because the T-cell mitogenic responses of nu/nu andfnu/+ spleen cells induced by purified IL-2 are nearly equivalent (Table 1) and because nu/ nu spleens used in this study possessed less than 4% T lymphocytes by immunofluorescence as compared to 25% in-nu/ + spleens. The absolute responses to IL-2 can approach the magnitude of Con A responses by nu/+ spleen cells, which are believed to represent polyclonal stimulation ofnearly all T lymphocytes (16) , thus implying that the nu/nu response to IL-2 could not arise solely from the less than 4% T lymphocytes already present in nu/nu spleens.
The presence ofT-cell precursors in nu/nu spleens has been described (23) (24) (25) , and maturation of such cells in vitro in the presence of thymic epithelium has previously been reported (26) . Whether such maturationdue to IL-2 occurs in the thymus is unknown, but it may, well be that one of the major roles of the thymus in lymphocyte maturation is to induce IL-2 production in a subpopulation of lymphocytes that is then persistent. Interestingly, helper T-cell' lines that produce IL-2 can survive and function in vivo in nu/nu mice, whereas killer Tcell lines, which are nonproducers of IL-2, do not survive in these animals (27) . Culture supernatants containing IL-2 are also reported to induce T-cell function in nu/nu mice when injected in vivo (28) . The induction ofself-perpetuating IL-2 producing cells by the thymus could explain the limited effects of adult thymectomy on immune function as opposed to the drastic T-cell deficiencies caused by neonatal thymectomy or congenital lack of this organ (29; 30).
Note Added in Proof. We have recently repeated all the spleen cell growth factor experiments described above, using instead partially purified IL-2 produced by the 
